围标串标！国药器械（山东）医药科技有限公司被暂停海军采购资格

Core Viewpoint - The military procurement network has announced a suspension of the procurement activities of China National Pharmaceutical Group Medical Device (Shandong) Co., Ltd. due to violations related to collusion in bidding [1][2][6]. Group 1: Company Information - China National Pharmaceutical Group Medical Device (Shandong) Co., Ltd. was established on February 24, 2012, and is a subsidiary of China Medical Device Shandong Co., Ltd. [8]. - The company is located at 3177 Yuehe Road, High-tech Industrial Park Incubator, Weifang Economic Development Zone, Shandong Province [8]. Group 2: Violation Details - The company is accused of engaging in collusion during the procurement activity identified by project number 2020-JHBATL-W1014 [2]. - As a result of the investigation, the company will be suspended from participating in naval material engineering service procurement activities starting from December 7, 2025 [3][8]. - The suspension also affects the legal representative Yu Hongzheng and the natural person controlling shareholder Sun Jinke, who are prohibited from managing or participating in other enterprises involved in military procurement during the suspension period [3]. Group 3: Regulatory Actions - The suspension is based on military supplier management regulations and is effective from December 7, 2025 [3][8]. - The specific reason for the suspension is identified as collusion in bidding [6].